Esperion Therapeutics, Inc.: capex
| Value | {"amount": 285762, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2008-01-22 – 2013-06-30 |
| Status | current |
| Entity | Esperion Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:06:41.078510+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/6daac8c5-14cc-41e2-b678-e73d297031c7
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-13-062514Retrieved: 2026-08-19T14:06:41.078510+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001434868/capex/2013-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/6daac8c5-14cc-41e2-b678-e73d297031c7
History
- no predecessors — first report